Share
Journal Information
Issue
Vol. 28. Issue 1.Pages 1-82 (January - February 2022)
Commentary
The COVID-19 impact on the scientific production on the 25 main death causes according to world region
Felipe Eduardo Valencise, Matheus Negri Boschiero, Camila Vantini Capasso Palamim, Fernando Augusto Lima Marson
Pulmonol. 2022;28:1-3
Open access
Editorial
Making IGRA testing easier: First performance report of QIAreach QFT for tuberculosis infection diagnosis
P. Miotto, D. Goletti, L. Petrone
Pulmonol. 2022;28:4-5
Open access
Original articles
Original articles
Tb
First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease
K. Fukushima, K. Akagi, A. Kondo, T. Kubo, N. Sakamoto, H. Mukae
Pulmonol. 2022;28:6-12
Open access
Original articles
Covid_19
COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU
María Laura Vega, Roberto Dongilli, Gustavo Olaizola, Nicolás Colaianni, Mauro Castro Sayat, Lara Pisani, Micaela Romagnoli, Greta Spoladore, ... Stefano Nava
Pulmonol. 2022;28:13-7
Open access
Practice of tracheostomy in patients with acute respiratory failure related to COVID–19 – Insights from the PRoVENT–COVID study
A.M. Tsonas, M. Botta, J. Horn, M.J. Brenner, M.S. Teng, B.A. McGrath, M.J. Schultz, F. Paulus, ... PRoVENT–COVID Collaborative Group
Pulmonol. 2022;28:18-27
Open access
Original articles
Lung cancer
Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancer
C. Centeno, P. Serra Mitja, M. Avila, E. Carcereny, A.M. Muñoz-Mármol, T. Moran, E. Castellà, J. Sanz-Santos, ... F. Andreo García
Pulmonol. 2022;28:28-33
Open access
Reviews
Severe asthma in the era of COVID-19: A narrative review
João Gaspar-Marques, Mafalda van Zeller, Pedro Carreiro-Martins, Cláudia Chaves Loureiro
Pulmonol. 2022;28:34-43
Open access
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries
Patrizia Pignatti, Dina Visca, Stelios Loukides, Anne-Grete Märtson, Jan-Willem C. Alffenaar, Giovanni Battista Migliori, Antonio Spanevello
Pulmonol. 2022;28:44-58
Open access
Letters to the editor
Outcomes of COVID-19 patients treated with noninvasive respiratory support outside-ICU setting: a Portuguese reality
L. Rodrigues Santos, R. Gonçalves Lopes, A.S. Rocha, M.D. Martins, T.C. Guimarães, M. Meireles, H. Vilaça, A. Castro, M. Mesquita
Pulmonol. 2022;28:59-61
Open access
SARS-CoV-2 as a trigger of eosinophilic pneumonia
M. Araújo, S. Correia, A.L. Lima, M. Costa, I. Neves
Pulmonol. 2022;28:62-4
Open access
Cycling biologic therapy for severe asthma
S. Hamada, E. Ogino, H. Yasuba
Pulmonol. 2022;28:65-7
Open access
Intra- and interobserver agreement of inspiratory capacity during cardio pulmonary exercise test
D. Mannée, T. Berens, B. van den Borst, H. van Helvoort
Pulmonol. 2022;28:68-9
Open access
Differences in exercise capacity and health-related quality of life according to the body mass index in patients with COPD
Jhonatan Betancourt-Peña, Juan Carlos Ávila-Valencia, Diana Milena Diaz-Vidal, Vicente Benavides-Córdoba
Pulmonol. 2022;28:70-2
Open access
Pulmonary function tests: The patient´s perspective
Marta Carvalho Silva, Inês Ladeira, Ricardo Lima, Miguel Guimarães
Pulmonol. 2022;28:73-5
Open access
ROS-1 TKI for the treatment of concurrent sarcomatoid transformation and acquired ROS-1 F2004C mutation in a lung adenocarcinoma patient
H.-J. Ko, C.-K. Hsu, Y.-C. Yeh, H.-C. Huang
Pulmonol. 2022;28:76-9
Open access
Lung cancer in young patients: natural history, biology and prognosis
I. Oliveira, P. Mota, T. Almodovar
Pulmonol. 2022;28:80-1
Open access
